Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-04-17
2007-04-17
Haddad, Maher M. (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007240
Reexamination Certificate
active
10169520
ABSTRACT:
Manipulation of the EphB6 receptor and its active Eph partners allow for regulation of T cell responses, including TCR signaling, T cell proliferation, and induction of T cell death. Methods of modulating EphB6 are described as well as various therapeutic applications.
REFERENCES:
patent: WO 96/26958 (1996-09-01), None
patent: WO 99/17796 (1999-04-01), None
patent: WO 00/30673 (2000-06-01), None
Freywald et al. The EphB6 receptor inhibits JNK activation in T lymphocytes and modulates T cell receptor-mediated responses. J Biol Chem. Mar. 21, 2003;278(12):10150-6.
Luo et al. EphB6-null mutation results in compromised T cell function. J Clin Invest. Dec. 2004;114(12):1762-73.
Kuntz ID. Structure-based strategies for drug design and discovery. Science. Aug. 21, 1992;257(5073):1078-82.
Meima et al. Lerk2 (ephrin-B1) is a collapsing factor for a subset of cortical growth cones and acts by a mechanism different from AL-1 (ephrin-A5). Mol Cell Neurosci. 1997;9(4):314-28.
Miller et al. Ligand binding to proteins: the binding landscape model. Protein Sci. Oct. 1997;6(10):2166-79.
Abraham, C., Griffith, J. & Miller, J. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand.J. Immunol162, 4399-405 (1999).
Adams, R.H. et al. Roles of ephrinB ligands adn EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.Genes Dev13, 295-306 (1999).
Aggarwal, S. S. Gollapudi, S. Gupta,J Immunol162,2154-61 (1999).
Alderson, M. R., et al.,J Exp Med181,71-7 (1995).
Baker, S. J., E. P. Reddy,Oncogene17,3261-70 (1998).
Bartley TD, Hunt RW, Welcher AA, Boyle WJ, Parker VP, Lindberg RA, Lu HS, Colombero AM, Elliott RL, Guthrie BA, et al.NatureApr. 7, 1994; 368 (6471): 558-60 B61 is a ligand for the ECK receptor protein-tyrosine kinase.
Becker, E. et al. Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation.Mol Cell Biol20,1537-45 (2000).
Blake, T. J., Shapiro, M., Morse, H.C.d. & Langdon, W. Y. The sequences of the human and mouse c-cb1 proto-oncogens show v-cb1 was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif.Oncogene6,653-7 (1991).
Blechman JM, Lev S, Brizzi MF, Leitner O, Pegoraro L, Givol D, Yarden Y,Biol ChemFeb. 25, 1993; 268 (6): 4399-406. Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor.
Blechman JM, Lev S, Barg J, Eisenstein M, Vaks B, Vogel Z, Givol D, Yarden Y Cell Jan. 13, 1995;80(1):103-13. The fourth immunoglobulin domains of the stem cell factor receptor couples ligand binding to signal transduction.
Bleijs, D. A., de Waal-Malefyt, R., Figdor, C.G. & van Kooyk, Y. Co-stimulation of T cells results in distinct IL-10 and TNF-alpha cytokine profiles dependent on binding to ICAM-1, ICAM-2, ICAM-3.Eur F Inimunol29, 2248-58, (1999).
Boehme, S.A., L. Zheng, M.J. Lenardo, J Immunol 155, 1703-12 (1995).
Bohme, B. et al. Cell-cell adhesion mediated by binding a membrane-anchored ligand LERK-2 to the EPH-related receptor human embryonal kinase 2 promotes tyrosine kinase activity.Journal of Biological Chemistry271, 24747-52 (1996).
Bonita, D.P., Miyake, S., Lupher, M.L., Jr., Langdon, W.Y. & Band, H. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cb1: implications for Cb1's function and oncogenicity.Mol Cell Biol17, 4597-610 (1997).
Brambilla, R. et al. Membrane-bounded LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases.Embo Journal14, 3116-26 (1995).
Chambers, C.A. & Allison, J.P. Co-stimulation in T cell responses.Curr Opin Immunol9, 396-404 (1997).
Choi, S. & Park, S. Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activity.Oncogene18, 5413-5422 (1999).
Chong, L.D., E.K. Park, E. Latimer, R. Friesel, I.O. Daar, Mol Cell Biol 20, 724-34 (2000).
Chou, Y.H. & Hayman, M.J. Characterization of a member of the immunoglobulin gene superfamily that possibly represents an additional class of growth factor receptor.Proc Natl Acad Sci USA88, 4897-901 (1991).
Ciossek, T. & Ullrich, A. Identification of Elf-1 and B61 as high affinity ligands for the receptor tyrosine kinase MDK1.Oncogene14, 35-43 (1997).
Ciossek, T. et al. Eph receptor-ligand interactions are necessary for guidance of retinal ganglion cell axons in vitro.Eur J Neurosci10, 1574-80 (1998).
Cross, J.V., et al., [J] Biol Chem 274, 31150-4 (1999).
Daniel, T.O. et al. ELK and LERK-2 in developing kidney and microvascular endothelial assembly.Kidney International Supplement(1996).
Davis, S. et al. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity.Science266, 816-9 (1994).
Dhein, J.,H. Walczak, C. Baumler, K.M. Debatin, P.H. Krammer, Nature 373,438-41 (1995).
Drescher, U. et al. In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases.Cell82, 359-70 (1995).
Drescher, U. The Eph family in the patterning of neural development.Current Biology7 (1997).
Durbin, L., et al. Development 127, 1703-13 (2000).
Dustin, M.L. & Shaw, A.S. Costimulation: building an immunological synapse.Science283, 649-50 (1999).
Dutting, D., C. Handwerker, U. Drescher, Dev Biol 216,297-311 (1999).
Birgbauer, E., C. A. Cowan, D. W. Sretavan, M. Henkemeyer, Development 127,1231-41 (2000).
Ellis, C. et al. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interactions with p59fyn.Oncogene12, 1727-36 (1996).
Flanagan, J.G. & Vanderhaeghen, P. The ephrins and Eph receptors in neural development.Annu Rev Neurosci21, 309-45 (1998).
Fournel, M., Davidson, D., Weil, R. & Veillette, A. Association of tyrosine protein kinase Zap- 70 with the protooncogene product p120C-cb1 in T lymphocytes.J Exp Med183, 301-6 (1996).
Friedman, G.C. & O'Leary, D.D. Eph receptor tyrosine kinases and their ligands in neural development.Current Opinion in Neurobiology6, 127-33 (1996).
Gale, N.W. et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during enbryogenesis.Neuron17, 9-19, (1996).
Gao, P.P., Yue, Y., Cerretti, D.P., Dreyfus, C. & Zhou, R. Ephrin-dependent growth and pruning of hippocampal axons.Proc Natl Acad Sci USA96, 4073-7 (1999).
Greginat, J., Bossi, G., Bender, J.R. & Pardi, R. Anchorage dependence of mitogen-induced G1 to S transition in primary T lymphocytes.J Immunol162, 5085-93 (1999).
Grakoui, A. et al. The immunological synapse: a molecular machine controlling T cell activation.Science285, 221-7 (1999).
Gurniak, C.B. & Berg, L.J. A new member of the Eph family of receptors that lacks protein tyrosine kinase activity.Oncogene13, 777-86 (1996).
Hattori, M., M. Osterfield, J.G. Flanagan, Science 289, 1360-5 (2000).
Helbling, P.M., D.M. Saulnier, A. W. Brandli, Development 127, 269-78 (2000).
Hock, B. et al. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions.Oncogene17, 255-260 (1998).
Holland, S.J. et al. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.Embo J16, 3877-88 (1997).
Holsinger, L.J. et al. Defects in actin-cap information in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction.Curr Biol8, 563-72 (1998).
Honegger, A.M., Schmidt, A., Ullrich, A. & Schlessinger, J. Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells.Molecular&Cellular Biology10, 4035-44 (1990).
Hornberger, M.R. et al. Modulation of EphA receptor
Freywald Andrew
Gruebaum Eyal
Grunberger Thomas
Roifman Chaim M.
Sharfe Nigel
Haddad Maher M.
Jagtiani & Guttag
The Hospital for Sick Children
LandOfFree
Methods of modulation of the immune system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of modulation of the immune system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of modulation of the immune system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3743140